Metabolic Pharmaceuticals terminates acquisition of PolyNovo Biomaterials - MarketLine Financial Deals

Metabolic Pharmaceuticals terminates acquisition of PolyNovo Biomaterials

Metabolic Pharmaceuticals terminates acquisition of PolyNovo Biomaterials - MarketLine Financial Deals
Metabolic Pharmaceuticals terminates acquisition of PolyNovo Biomaterials
Published Dec 01, 2008
3 pages — Published Dec 01, 2008
Price US$ 45.00  |  Buy this Report Now

About This Report

  
Abstract:

Metabolic Pharmaceuticals Limited, a biotechnology company, has terminated the share sale agreement to acquire PolyNovo Biomaterials Pty., Ltd., a developer of biodegradable polymers for use in medical devices, from Xceed Capital Limited, a biotechnology company, and Commonwealth Scientific and Industrial Research Organization (CSIRO).

  
Source:
Document ID
MA00727_081201
Country
Ticker
MBLPF=AU
Ticker
XCD=AU
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Metabolic Pharmaceuticals terminates acquisition of PolyNovo Biomaterials" Dec 01, 2008. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Metabolic-Pharmaceuticals-terminates-acquisition-of-PolyNovo-Biomaterials-2052-663>
  
APA:
MarketLine Financial Deals. (2008). Metabolic Pharmaceuticals terminates acquisition of PolyNovo Biomaterials Dec 01, 2008. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Metabolic-Pharmaceuticals-terminates-acquisition-of-PolyNovo-Biomaterials-2052-663>
  
US$ 45.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.